Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Vivos Inc.

Market Cap 31.05M 27.07M 25.07M 23.47M 44.02M 2.93B 44.29M 297M 115M 1.44B 117M 114M 5.01B P/E 2024
-16.2x
P/E 2025 -10.2x
Enterprise Value 29.61M 25.81M 23.91M 22.38M 41.97M 2.79B 42.23M 284M 110M 1.38B 111M 109M 4.77B EV / Sales 2024
1,724x
EV / Sales 2025 438x
Free-Float
95.83%
Yield 2024 *
-
Yield 2025 -
1 day-2.66%
1 week-3.23%
Current month-8.71%
1 month-5.98%
3 months-30.11%
6 months-9.63%
Current year-8.71%
1 week 0.06
Extreme 0.0558
0.07
1 month 0.06
Extreme 0.0558
0.07
Current year 0.06
Extreme 0.0558
0.09
1 year 0.04
Extreme 0.0425
0.15
3 years 0.04
Extreme 0.0412
0.26
5 years 0.04
Extreme 0.04
0.26
10 years 0.01
Extreme 0.0065
8
Manager TitleAgeSince
Chief Executive Officer 79 2016-12-13
President 44 2025-09-14
Director of Finance/CFO 59 2018-11-30
Director TitleAgeSince
Chairman 81 2016-12-13
Director/Board Member 79 2017-08-01
Date Insider Type Main position Quantity % Market Cap.
05-10Buy

Chief Executive Officer

150,000 0.0311%
12-30Buy

Chief Executive Officer

200,000 0.0440%
12-01Buy

Chief Executive Officer

100,000 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
-2.66%-3.23%-48.65%+5.01% 31.05M
-5.99%-9.24%-19.45%-24.47% 12.54B
-0.26%+7.72%+93.53%+22.87% 5.27B
-1.04%-3.45%-36.22%-65.08% 1.21B
+1.69%-0.95%-32.67%-43.30% 1.19B
+1.22%-1.50%+58.31%+92.56% 1.18B
-0.53%-3.60%-37.73% - 949M
-5.27%-1.71%+213.40%+194.59% 704M
+1.69%-8.07% - - 330M
-0.74%-0.55%-57.45%+200.00% 247M
Average -1.19%-2.18%+14.78%+47.77% 2.36B
Weighted average by Cap. -3.31%-3.87%+14.31%-0.94%

Financials

2024 2025
Net sales 28K 24.41K 22.61K 21.16K 39.69K 2.64M 39.93K 268K 104K 1.3M 105K 103K 4.51M 68.38K 59.62K 55.22K 51.69K 96.94K 6.45M 97.53K 655K 254K 3.18M 257K 251K 11.03M
Net income -2.91M -2.54M -2.35M -2.2M -4.13M -275M -4.15M -27.88M -10.81M -135M -10.92M -10.69M -469M -3.07M -2.67M -2.48M -2.32M -4.35M -289M -4.37M -29.37M -11.38M -142M -11.51M -11.26M -494M
Net Debt -2.21M -1.93M -1.79M -1.67M -3.14M -209M -3.16M -21.2M -8.21M -103M -8.31M -8.13M -357M -1.44M -1.26M -1.17M -1.09M -2.05M -136M -2.06M -13.84M -5.36M -67.08M -5.42M -5.31M -233M
Logo Vivos Inc.
Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.
Employees
1
Date Price Change Volume
26-06-18 0.0629 $ -2.66% 1,087,326
26-06-17 0.0646 $ +6.11% 1,500,853
26-06-16 0.0609 $ -8.13% 2,502,269
26-06-15 0.0663 $ +1.98% 419,019
26-06-12 0.0650 $ +1.56% 642,129
  1. Stock Market
  2. Stocks
  3. RDGL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!